A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current care.
Research delivered through the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) has contributed to improved diagnostic guidelines for identifying and managing asthma, announced by NICE last week.
New research from the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) has shown the chance of being correctly diagnosed with asthma varies widely depending on which national or international guidelines are followed.
Researchers at The University of Manchester in collaboration with Manchester University NHS Foundation Trust are launching a new Cystic Fibrosis Innovation Hub to accelerate the development of new tests and treatment approaches for lung infections.
Low dose morphine has the potential to treat chronic cough in people with idiopathic pulmonary fibrosis, according to new research from NIHR Manchester BRC and NIHR Imperial BRC.
In this blog, Clinical Research Fellow and PhD student Dr James Wingfield Digby shares his insights from the NIHR Associate Principal Investigator training scheme, which gave him practical experience of delivering clinical research.
Researchers are addressing several of the most common causes of death and disability, in our region and nationally, through our Inflammation Cluster. Find out more about the range and impact of our cutting-edge research in the first film of our new Spotlight On series.
As part of World Antimicrobial Awareness Week (18 to 24 November 2023), Dr Jan Hansel discusses the importance of therapeutic drug monitoring in limiting the development of antimicrobial resistance (AMR) and the new Manchester BRC-funded TDM-TIME study which he is leading.